* All times shown in GMT

8:30 am
Morning Networking Coffee

8:55 am Chair’s Opening Remarks

  • Mark Awadalla Vice President, Clinical Development, Capricor Therapeutics

Evaluating Preclinical Data for Effective Translation into the Clinic

9:30 am Progressing to Trials: Overview of Discovery & Pre-Clinical Efforts for Platelet Exosome Product Underpinning Translation to Clinical Application

Synopsis

For session details download our full event guide

10:00 am A Developer’s Perspective: Progressing from MSC therapy to Clinical POC for MSC-derived EVs

Synopsis

For session details download our full event guide

10:30 am
Morning Networking & Scientific Poster Session

Track A:

Discovery & Pre-Clinical Track

Revealing Innovation in Exosome Engineering to Boost Efficacy of Therapeutic Payloads

Synopsis

Chair: Craig Newton, Founder & Director, Vivazome Therapeutic

11:30 am Engineered ARMMs for Delivery of Therapeutic Payloads

Synopsis

For session details download our full event guide

12:00 pm Engineered Exosomes for the Treatment of Colorectal Cancer

Synopsis

For session details download our full event guide

Track B:

Clinical Development & Manufacturing Track

Discovering Approaches to GMP Manufacturing to Support Clinical Trials

11:30 am Panel Discussion: Approaches to GMP Manufacturing to Enable Clinical Studies

  • Michael Bellio Director & Vice President - Laboratory Research & Manufacturing, Organicell Regenerative Medicine
  • Davide Zocco Head of Exosomes Development & Site, Lonza

Synopsis

Moderator: Maroun Khoury, Chief Scientific Officer, Cells for Cells, Co-founder & Chief, Scientific Officer, EVast Bio

For session details download our full event guide

12:00 pm Manufacturing & Testing Amniotic Fluid-derived EVs at Scale for Early to Mid-Stage Clinical Trials.

  • Michael Bellio Director & Vice President - Laboratory Research & Manufacturing, Organicell Regenerative Medicine

Synopsis

For session details download our full event guide

12:30 pm
Networking Lunch Break

Leveraging the Targeted Delivery Capabilities of T-Reg & RBC Derived Exosomes for Improved Efficiency

1:30 pm How RBC Extracellular Vesicle Derived Vectors are Solving Challenges in the Non-Viral Gene Delivery Space

Synopsis

For session details download our full event guide

2:00 pm Rapid Functionalization of Treg Exosomes for Targeted Immunotherapies

  • Phil Campbell Research Professor, Carnegie Mellon University, Coya Therapeutics

Synopsis

For session details download our full event guide

Addressing Scalability Challenges to Retain Quality & Achieve Consistency at Large-Scale Productions

1:30 pm Moving Large-Scale Platform MSCs Derived EVs to Human Medical Needs

Synopsis

For session details download our full event guide

2:00 pm Preclinical Study of Intraocular EV Therapy For Retinal Diseases & Efforts To Establish Scalable & Good Manufacturing Practice (GMP) Compatible EV Production

Synopsis

For session details download our full event guide

2:30 pm
Afternoon Networking Break

Discover Emerging Frontiers of Exosome & EV Based Therapeutics of the Future

3:00 pm Panel Discussion: Putting Exosomes on the Map; the Rising Star of Drug Delivery

Synopsis

For session details download our full event guide

4:00 pm Secretomes as a Novel Therapeutic Modality

Synopsis

For session details download our full event guide

4:30 pm
Chairs Closing Remarks & End of 5th Exosome Based Therapeutics Summit
  • Mark Awadalla Vice President, Clinical Development, Capricor Therapeutics